Regulation of glutamine carrier proteins by RNF5 determines breast cancer response to ER stress-inducing chemotherapies
about
SLC transporters as a novel class of tumour suppressors: identity, function and molecular mechanismsAmino acid management in cancerDysregulation of ubiquitin ligases in cancerTumorigenic and Immunosuppressive Effects of Endoplasmic Reticulum Stress in CancerAmino acid homeostasis and signalling in mammalian cells and organisms.Attacking the supply wagons to starve cancer cells to death.Genetic Inhibition Of The Ubiquitin Ligase Rnf5 Attenuates Phenotypes Associated To F508del Cystic Fibrosis Mutation.High expression of Solute Carrier Family 1, member 5 (SLC1A5) is associated with poor prognosis in clear-cell renal cell carcinomaATF4 induction through an atypical integrated stress response to ONC201 triggers p53-independent apoptosis in hematological malignancies.EGFR kinase domain mutation positive lung cancers are sensitive to intrapleural perfusion with hyperthermic chemotherapy (IPHC) complete treatment.miR-216b regulation of c-Jun mediates GADD153/CHOP-dependent apoptosisASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer.Deletion of Amino Acid Transporter ASCT2 (SLC1A5) Reveals an Essential Role for Transporters SNAT1 (SLC38A1) and SNAT2 (SLC38A2) to Sustain Glutaminolysis in Cancer Cells.Positive feedback regulation of p53 transactivity by DNA damage-induced ISG15 modification.How does metabolism affect cell death in cancer?Glutamine at focus: versatile roles in cancer.Glutamine transporters in mammalian cells and their functions in physiology and cancer.Nutritional Stress Induced by Tryptophan-Degrading Enzymes Results in ATF4-Dependent Reprogramming of the Amino Acid Transporter Profile in Tumor Cells.Intercellular transmission of the unfolded protein response promotes survival and drug resistance in cancer cells.Metabolomics Analysis of Hormone-Responsive and Triple-Negative Breast Cancer Cell Responses to Paclitaxel Identify Key Metabolic Differences.Natural products as modulator of autophagy with potential clinical prospects.Glutaminase and poly(ADP-ribose) polymerase inhibitors suppress pyrimidine synthesis and VHL-deficient renal cancers.Early Administration of Glutamine Protects Cardiomyocytes from Post-Cardiac Arrest Acidosis.Right on TARGET: glutamine metabolism in cancer.Oncogene-Driven Metabolic Alterations in Cancer.Phosphoglycerate Kinase 1 Phosphorylates Beclin1 to Induce Autophagy.The inhibition of UBC13 expression and blockage of the DNMT1-CHFR-Aurora A pathway contribute to paclitaxel resistance in ovarian cancer.Functional significance and therapeutic implication of ring-type E3 ligases in colorectal cancer.Unfolded Protein Response of the Endoplasmic Reticulum in Tumor Progression and Immunogenicity.PPARδ promotes tumor progression via activation of Glut1 and SLC1-A5 transcription.Sorting Nexin 27 (SNX27) regulates the trafficking and activity of the glutamine transporter ASCT2.A VCP inhibitor substrate trapping approach (VISTA) enables proteomic profiling of endogenous ERAD substrates.Metabolic Features of Multiple Myeloma.Amino Acid Transporters and Glutamine Metabolism in Breast Cancer.Metabolic Reprogramming and the Recovery of Physiological Functionality in 3D Cultures in Micro-Bioreactors.Benzylserine inhibits breast cancer cell growth by disrupting intracellular amino acid homeostasis and triggering amino acid response pathways.IRE1α-XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activityRegulation of S100A8 Stability by RNF5 in Intestinal Epithelial Cells Determines Intestinal Inflammation and Severity of ColitisThe Human SLC1A5 (ASCT2) Amino Acid Transporter: From Function to Structure and Role in Cell BiologyAn anti-ASCT2 monoclonal antibody suppresses gastric cancer growth by inducing oxidative stress and antibody dependent cellular toxicity in preclinical models
P2860
Q26749468-DA9D2BC1-D403-4B40-B089-435BFC608607Q26798087-CEB6D395-7226-4A94-9BB1-98D80378B8B2Q28086796-5938E506-BE4F-4433-B856-9416E7990F92Q29248711-A882E790-9ABD-4364-88D9-F05F04EADFD2Q33727454-6C1283E7-4B6E-4654-A37F-21568B53D8DAQ34516773-5C12A534-108B-450B-AAA4-B71ADF16539AQ35693982-0FD6A0CE-B083-4627-BEAC-55EF2B2B563AQ36310209-93E38D8B-F6ED-4A20-A90F-42B6A4E06BD8Q36748678-48FA0012-A248-41EA-A023-8B7C69C385FCQ36772144-4528622A-DE19-4954-A5D9-0A58F77A3B61Q36906971-A9F198A0-134D-4F1C-89D1-BC6E80D313CBQ37023688-1C7366BC-167B-480C-8A1D-9C3E7D01575DQ37065899-221F9EF4-5B68-435D-B974-354966DAC2EFQ37201724-6BB30687-1DDC-4918-A9C2-89AAE298F5FCQ38615890-86A6686A-71B6-485D-98F7-C43677958ADFQ38678184-6AC9741F-2144-4D77-9D28-981FCF028086Q38685207-BD0501C9-F939-4AEC-86A1-E9B4E5CB831BQ38734317-97CFB67D-7865-4A2E-BA71-B815868E0316Q38739821-FE6D145F-2DAA-4BD1-8C09-465B11D8E6A7Q38756385-36EB33EC-3CDD-463E-AEAC-E5C21C907ED0Q39042339-2BA92594-DF6F-484C-84AF-67C99DEB3B4CQ41887078-63F129AE-9867-4A13-B5C0-60D88F1B500EQ42343036-344B104C-8450-455B-BBF7-9DBAA2CCDF08Q43242538-72B01118-E41C-4B77-9499-EBABA9FFF229Q47159555-598A60F1-F6F0-46AA-B2F1-5A7B31DABFF7Q47964526-A0C63B35-B474-44EB-AD42-AE79B77EECA0Q49724590-B628EA3A-4F91-4C58-A65B-6FB2ED454CF9Q50026061-0A39CB9B-81C2-4DA9-AD5B-C840169ECE37Q50073383-0CED29CF-5EE3-47AA-87BF-2107349D7D53Q50656567-80DC870C-761F-4EDA-BCD4-A3A7D9A5BBA7Q51736976-BB785C4D-8573-473D-84FC-30D2784ED9EAQ52668654-AC1AA551-BB0F-49F3-BDAC-158512A3E688Q53694850-1D1B0040-DF97-49F7-A88A-933896F556A6Q54957053-2E802B57-2EFE-4572-B90C-A1DD4BDB65AAQ55406400-4AEBDD01-BC12-4912-88E3-7DF51C238E28Q55435354-3562CDC7-B4C8-40C8-AD79-E10CC2591C5BQ57285558-F8C9430A-B8A5-4089-BFC5-02D6F588CC90Q58721652-628C6C4C-407F-407E-B653-7C1C69C093EDQ58764807-B0458FDF-CFB7-45B9-93D8-D8D15C0CE47DQ58804578-3029DBB6-3367-4952-B798-B04C3C6D46AE
P2860
Regulation of glutamine carrier proteins by RNF5 determines breast cancer response to ER stress-inducing chemotherapies
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Regulation of glutamine carrie ...... stress-inducing chemotherapies
@ast
Regulation of glutamine carrie ...... stress-inducing chemotherapies
@en
Regulation of glutamine carrie ...... stress-inducing chemotherapies
@en-gb
Regulation of glutamine carrie ...... stress-inducing chemotherapies
@nl
type
label
Regulation of glutamine carrie ...... stress-inducing chemotherapies
@ast
Regulation of glutamine carrie ...... stress-inducing chemotherapies
@en
Regulation of glutamine carrie ...... stress-inducing chemotherapies
@en-gb
Regulation of glutamine carrie ...... stress-inducing chemotherapies
@nl
prefLabel
Regulation of glutamine carrie ...... stress-inducing chemotherapies
@ast
Regulation of glutamine carrie ...... stress-inducing chemotherapies
@en
Regulation of glutamine carrie ...... stress-inducing chemotherapies
@en-gb
Regulation of glutamine carrie ...... stress-inducing chemotherapies
@nl
P2093
P2860
P921
P3181
P1433
P1476
Regulation of glutamine carrie ...... stress-inducing chemotherapies
@en
P2093
Andrei L Osterman
Boris Ratnikov
Chelsea Ruller
David A Scott
David L Rimm
Fabio Parisi
Gordon B Mills
Jeffrey W Smith
Laurence M Brill
P2860
P304
P3181
P356
10.1016/J.CCELL.2015.02.006
P407
P577
2015-03-01T00:00:00Z